Skip to main content
. 2016 May 20;7(27):41677–41690. doi: 10.18632/oncotarget.9528

Table 2. Genes associated with reduced OS at TP1.

Gene expression in Non-Responders at TP1 p-value Hazard ratio 95% CI of ratio
ERCC1 0,0031 0.04723 0.006212 to 0.3591
EGFR 0,0084 0.01274 0.0004959 to 0.3274
ERCC1 + ERBB2 0,0293 0.4091 0.1590 to 0.6592
ERCC1 + ERBB3 0,0084 0.2727 0.06499 to 0.4805
ERCC1 + AURKA 0,0094 0.3636 0.1135 to 0.6137
EGFR + AURKA 0,0084 0.2727 0.06499 to 0.04805
EGFR + ERBB3 0,0084 0.2727 0.06499 to 0.04805

The genes and gene combinations listed were significantly associated with a shorter OS. For Responders, no significant single gene or combinations could be identified.